Clinical Trial Update: Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 trial assessing safety and efficacy of sotagliflozin in patients with inadequately controlled type 1 diabetes mellitus completed with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Sotagliflozin (sotagliflozin)

Snippet

Sponsor: Lexicon Pharmaceuticals | Conditions: Type 1 Diabetes Mellitus | Phase 2 | Status: COMPLETED | Results posted: 2019-10-30